KNSA
Asset Logo

Kiniksa Pharmaceuticals International Plc

🇺🇸 NYSE/NASDAQ

📈 HIGH PRICE GROWTH

Compare
Add to watchlist
👑 Overview

📈 Performance

💵 Cost

🍃 Esg

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

+ 27.18%
Annual Growth

5 years average annual growth

🌏

1
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

Kiniksa Pharmaceuticals, Ltd. is a biopharmaceutical company. The Company is focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. Its portfolio of immune-modulating assets, ARCALYST (rilonacept), KPL-404 and mavrilimumab, are based on strong biologic rationale or validated mechanisms, target a spectrum of underserved cardiovascular and autoimmune conditions, and offer the potential for differentiation. The Company’s ARCALYST is interleukin-1alpha (IL-1α), and interleukin-1beta (IL-1β), cytokine trap for the treatment of recurrent pericarditis and reduction in risk of recurrence in adults and children. Its KPL-404 is an investigational monoclonal antibody inhibitor of CD40-CD154 interaction. The Company’s Mavrilimumab is an investigational monoclonal antibody inhibitor targeting granulocyte-macrophage colony stimulating factor receptor alpha (GM-CSFRα).

📈 Performance

Price History*

+7.41%

1M

1Y

All Time

Graph

Table

* US price history does not take into account stock splits

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

N/A
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🤓 Advanced information

Technical Info

💰 Price*

$21.09

*Price may be up to 24 hours old

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in KNSA

1

📊 Total Capital Earnings

N/A

🔃 Average investment frequency

3 days

💵 Average investment amount

$244

Last time a customer invested in KNSA

231 days
KNSA investor breakdown
💵 Income of investors

More than 200k

150k - 200k

100k - 150k

50k - 100k

100%

Less than 50k

👶 Age of investors

18 - 25

26 - 34

35 - 90

100%
🙋 Legal gender of investors

Female

Male

100%

Pearlers who invest in KNSA also invest in...

Adobe Systems Inc.

ADBE

🙌 Performance (5Yr p.a)

13.76%

📊 Share price

$504.44 USD

📈 HIGH PRICE GROWTH

Find Out More

🙌 Performance (5Yr p.a)

1011.75%

📊 Share price

$167.63 USD

🙌 Performance (5Yr p.a)

-1.00%

📊 Share price

$202.81 USD

🙌 Performance (5Yr p.a)

49.77%

📊 Share price

$228.52 USD

📈 HIGH PRICE GROWTH

📊 Share price

$30.56 USD

Want more shares? Try these...

🙌 Performance (5Yr p.a)

82.32%

📊 Share price

$489.92 USD

📊 Share price

$18.93 USD
Compare
Add to watchlist